Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Marchetti

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Revue Medicale Suisse|May 18, 2005
[Utility of procalcitonin for the diagnosis and the follow-up of infections in febrile neutropenic patients]J O Robinson, T Calandra, O Marchetti
Thrombosis and Haemostasis|November 2, 1999
Hemostatic activation under anticoagulant treatment: a comparison of unfractionated heparin vs. nadroparin in the treatment of proximal deep vein thrombosisH Stricker, O Marchetti, A Haeberli, et al.
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales|January 1, 1982
[Tachycardia induced by a hot bath]G Camus, O Marchetti, J Juchmes, et al.
Revue Medicale Suisse|June 27, 2008
[Empirical antibiotic therapy for febrile neutropenia]R Kridel, C Van Delden, T Calandra, et al.
American Heart Journal|December 8, 1998
Effect of intravenous heparin infusion on thrombin-antithrombin complex and fibrinopeptide A in unstable anginaG Mombelli, O Marchetti, A Haeberli, et al.
Antimicrobial Agents and Chemotherapy|August 4, 1998
Y-688, a new quinolone active against quinolone-resistant Staphylococcus aureus: lack of in vivo efficacy in experimental endocarditisJ M Entenza, O Marchetti, M P Glauser, et al.
Antimicrobial Agents and Chemotherapy|August 22, 2000
Potent synergism of the combination of fluconazole and cyclosporine in Candida albicansO Marchetti, P Moreillon, M P Glauser, et al.
Journal Francais D'Ophtalmologie|June 25, 2005
[Anterior segment necrosis in multidrug-resistant Fusarium keratomycosis: a case study]F Gianoli, Y Guex-Crosier, O Marchetti, et al.
Bone Marrow Transplantation|September 20, 2011
ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipientsO Marchetti, F Lamoth, M Mikulska, et al.
Antimicrobial Agents and Chemotherapy|December 3, 2008
Reassessment of recommended imipenem doses in febrile neutropenic patients with hematological malignanciesF Lamoth, T Buclin, C Csajka, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Revue Medicale Suisse|May 18, 2005
[Utility of procalcitonin for the diagnosis and the follow-up of infections in febrile neutropenic patients]J O Robinson, T Calandra, O Marchetti
Thrombosis and Haemostasis|November 2, 1999
Hemostatic activation under anticoagulant treatment: a comparison of unfractionated heparin vs. nadroparin in the treatment of proximal deep vein thrombosisH Stricker, O Marchetti, A Haeberli, et al.
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales|January 1, 1982
[Tachycardia induced by a hot bath]G Camus, O Marchetti, J Juchmes, et al.
Revue Medicale Suisse|June 27, 2008
[Empirical antibiotic therapy for febrile neutropenia]R Kridel, C Van Delden, T Calandra, et al.
American Heart Journal|December 8, 1998
Effect of intravenous heparin infusion on thrombin-antithrombin complex and fibrinopeptide A in unstable anginaG Mombelli, O Marchetti, A Haeberli, et al.
Antimicrobial Agents and Chemotherapy|August 4, 1998
Y-688, a new quinolone active against quinolone-resistant Staphylococcus aureus: lack of in vivo efficacy in experimental endocarditisJ M Entenza, O Marchetti, M P Glauser, et al.
Antimicrobial Agents and Chemotherapy|August 22, 2000
Potent synergism of the combination of fluconazole and cyclosporine in Candida albicansO Marchetti, P Moreillon, M P Glauser, et al.
Journal Francais D'Ophtalmologie|June 25, 2005
[Anterior segment necrosis in multidrug-resistant Fusarium keratomycosis: a case study]F Gianoli, Y Guex-Crosier, O Marchetti, et al.
Bone Marrow Transplantation|September 20, 2011
ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipientsO Marchetti, F Lamoth, M Mikulska, et al.
Antimicrobial Agents and Chemotherapy|December 3, 2008
Reassessment of recommended imipenem doses in febrile neutropenic patients with hematological malignanciesF Lamoth, T Buclin, C Csajka, et al.
Pageof 3